You are here
MYCOLOGICS, INC.
UEI: N/A
# of Employees: N/A
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Leishmania major nucleoside hydrolase inhibitors
Amount: $101,950.00DESCRIPTION (provided by applicant): Leishmania are typanosomatid protozoans that are transmitted by phlebotomine sand flies causing leishmaniasis. Leishmaniasis is a zoonosis and affects 12 million p ...
STTRPhase I2007Department of Health and Human Services National Institutes of Health -
A novel vaccine against Leishmania
Amount: $100,000.00DESCRIPTION (provided by applicant): Leishmania are typanosomatid protozoans that are transmitted by phlebotomine sand flies causing leishmaniasis. Leishmaniasis affects 12 million people in 88 countr ...
SBIRPhase I2005Department of Health and Human Services National Institutes of Health -
New drugs for the treatment of leishmaniasis
Amount: $100,000.00DESCRIPTION (provided by applicant): Leishmania are typanosomatid protozoans that are transmitted by phlebotomine sand flies causing leishmaniasis. Leishmaniasis is a zoonosis and affects 12 million p ...
SBIRPhase I2004Department of Health and Human Services National Institutes of Health -
A novel recombinant vaccine against Cryptococcus.
Amount: $99,999.00DESCRIPTION (provided by applicant): Cryptococcus neoformans is an encapsulated pathogenic yeast that causes pulmonary infections and meningoencephalitis in humans and other animals. During the last ...
STTRPhase I2004Department of Health and Human Services National Institutes of Health -
A novel recombinant vaccine against Cryptococcus.
Amount: $99,999.00DESCRIPTION (provided by applicant): Cryptococcus neoformans is an encapsulated pathogenic yeast that causes pulmonary infections and meningoencephalitis in humans and other animals. During the last ...
SBIRPhase I2004Department of Health and Human Services National Institutes of Health -
The glyoxylate cycle as a new target for antifungals
Amount: $100,000.00DESCRIPTION (provided by applicant): Fungi cause a wide spectrum of disease states. The most common examples are relatively minor, localized infections of the skin and mucous membranes such as athle ...
SBIRPhase I2003Department of Health and Human Services National Institutes of Health -
Antifungal drugs: Beta(1,6)-glucan synthesis inhibitors
Amount: $100,000.00DESCRIPTION (provided by applicant): Fungi cause a wide spectrum of disease states. The most common examples are relatively minor, localized infections of the skin and mucous membranes such as athlete ...
SBIRPhase I2003Department of Health and Human Services National Institutes of Health -
Inhibitors of transcription of fungal glucan synthase
Amount: $100,000.00DESCRIPTION (provided by applicant): Perhaps the most striking difference between fungal cells and human cells is that fungal cells are encased in a wall that protects them from an osmotically and im ...
SBIRPhase I2003Department of Health and Human Services National Institutes of Health -
A novel yeast vaccine against Coccidioides Immitis
Amount: $99,997.00DESCRIPTION (provided by applicant): Coccidioidomycosis, also known as San Joaquin Valley Fever, is a fungal disease caused by Coccidioides immitis that is endemic in portions of Southern Arizona, cen ...
SBIRPhase I2003Department of Health and Human Services National Institutes of Health -
A novel vaccine for Aspergillus fumigatus
Amount: $99,997.00DESCRIPTION (provided by applicant): Aspergillus fumigatus is a ubiqutous spore-bearing fungus that causes multiple diseases in humans. These include allergic pulmonary asthma, aspergillomas, and inva ...
SBIRPhase I2003Department of Health and Human Services National Institutes of Health
